Stock Activity Watchlist: Sunstone Hotel Investors (NYSE:SHO), Equifax (NYSE:EFX), Broadwind Energy (NASDAQ:BWEN), Dicerna Pharmaceuticals (NASDAQ:DRNA)

On 06 October, Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares decreased -1.71% and was closed at $130.53. JAZZ EPS growth in last 5 year was 43.30%. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) year to date (YTD) performance is -20.28%.

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for defibrotide. Defibrotide is an investigational agent proposed for the treatment of patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with evidence of multi-organ dysfunction (MOD) following hematopoietic stem-cell transplantation (HSCT).

Sunstone Hotel Investors Inc. (NYSE:SHO) shares increased 0.79% in last trading session and ended the day at $14.12. SHO Gross Margin is 63.90% and its has a return on assets of 2.20%. Sunstone Hotel Investors Inc. (NYSE:SHO) quarterly performance is -9.44%.

Sunstone Hotel Investors Inc. (NYSE:SHO) announced that John Arabia, President and Chief Executive Officer, will participate in a panel discussion at the Evercore ISI 2015 Real Estate Conference. The presentation will take place at 11:25 a.m. EDT on Thursday, October 8, 2015 in New York, NY.

On 06 October, Equifax Inc. (NYSE:EFX) shares fell -0.01% and was closed at $100.94. EFX EPS growth in last 5 year was 11.80%. Equifax Inc. (NYSE:EFX) year to date (YTD) performance is 25.92%.

Equifax Inc. (NYSE:EFX), a U.S. data management company, made a sweetened A$2.39 billion ($1.7 billion) offer for Australia’s Veda Group Ltd., gaining exclusive access to the target’s accounts.
The Atlanta-based firm offered A$2.825 per share in cash for the Australian credit information provider — compared with its initial offer of A$2.70 last month — Veda said in a statement to the stock exchange Tuesday. The Sydney-based company’s board unanimously recommended the offer.

Broadwind Energy, Inc. (NASDAQ:BWEN) shares increased 6.23% in last trading session and ended the day at $2.90. BWEN Gross Margin is 5.30% and its has a return on assets of -7.20%. Broadwind Energy, Inc. (NASDAQ:BWEN) quarterly performance is -18.77%.

Broadwind Energy, Inc. (NASDAQ:BWEN) announced $6 million in new gearing orders to be produced by its Brad Foote Gear Works, Inc. subsidiary. Broadwind President and CEO Peter Duprey stated, “As the fleet of more than 48,000 wind turbines installed in the U.S. starts to age, we are seeing growing opportunities for replacement wind gearing which is helping to offset weak oil and gas and mining orders.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) caters to the Healthcare space. Its weekly performance is 2.62%. On the last day of trading company shares ended up at $8.24. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) distance from 50-day simple moving average (SMA50) is -22.46%.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), announced that on September 30, 2015, the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 195,700 shares of common stock to six new employees, with all six grants having a grant date of September 30, 2015 (the “Q3 2015 Inducement Grants”).